«

»

Antibody Therapy From GSK, Vir Goes To Phase 3 Trials

The global trial of the experimental antibody therapy will expand following promising safety results in early trial participants.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive